NCT05419427View on ClinicalTrials.gov

Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis

PHASE3RecruitingINTERVENTIONAL
Enrollment

552

Participants

Timeline

Start Date

November 11, 2021

Primary Completion Date

September 11, 2024

Study Completion Date

November 24, 2024

Conditions
Osteoporosis, Postmenopausal
Interventions
DRUG

Denosumab

Denosumab 60 MG/ML

DRUG

Denosumab-Ref

Denosumab 60 MG/ML

Trial Locations (1)

302001

RECRUITING

S. R. Kalla Memorial Gastro & General Hospital, Jaipur

Sponsors
All Listed Sponsors
collaborator

Intas Pharmaceutical Limited (Biopharma Division)

UNKNOWN

lead

Lambda Therapeutic Research Ltd.

INDUSTRY